Dermira’s acne drug fails in two phase 3 trials

This article was originally published here

Dermira said that two phase 3 clinical trials testing its acne drug, olumacostat glasaretil, failed to meet their co-primary endpoints.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply